Gilead Sciences Inc. (GILD) said it has closed its sale of $1.1 billion of 1.00% convertible senior notes due 2014 and $1.1 billion of 1.625% convertible senior notes due 2016.
The net proceeds from this offering were about $2.166 billion, after deducting estimated discounts, commissions and expenses.
Gilead granted the underwriters a 13-day option to purchase up to $150 million of additional 2014 notes and up to $150 million of additional 2016 notes. No portion of the option has been exercised to date.
The company said it has already used about $248 million of the net proceeds from the offering to repurchase shares of its common stock and expects to use at least another $752 million of the net proceeds from the offering to repurchase shares of its common stock, in each case pursuant to its previously announced $5 billion stock repurchase program.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.